Alimentary Pharmacology & Therapeutics · 2010 · 54 citations · 51 references
MedicineInternal MedicineNutritionCost-utility AnalysisEarly DetectionPharmacoeconomic ModelingCeliac DiseaseCost-effectiveness ComparisonDiagnostic EvaluationModel-based Economic EvaluationPopulation ScreeningScreeningAdherenceCeliac Disease In AdultsComparative Cost-effectivenessCost-effectivenessCost-effectiveness Of Diagnostic TestingHealth Economics Of ScreeningMarkov Disease ModelsOutcome Measures
BACKGROUND: Coeliac disease is frequently diagnosed after a long delay resulting in increased morbidity and mortality. AIMS: To define the parameters which have the highest impact on the cost-effectiveness of mass screening for coeliac disease. METHODS: A Markov model examined a coeliac disease screening programme of the healthy young-adult general population compared with a no-screening strategy. The main outcome measures were quality adjusted life-years (QALYs) and incremental cost-effectiveness ratio (ICER). Effects of variables were examined using sensitivity analyses. RESULTS: The screening strategy resulted in a gain of 0.0027 QALYs. The ICER of screening vs. no-screening strategy was US$48,960/QALYs. The variables with the largest impact on cost effectiveness were: the time delay from symptom onset to diagnosis, the utility of adherence to a gluten-free diet (GFD) and the prevalence of coeliac disease. Screening would be cost-effective if the time delay to diagnosis is longer than 6 years and utility of GFD adherence is greater than 0.978. CONCLUSIONS: Our model suggests that mass screening for coeliac disease of the young-adult general population is associated with improved QALYs and is a cost effectiveness strategy. Shortening of the time-delay to diagnosis by heightened awareness of health-care professionals may be a valid alternative to screening.
51
Prevalence of Celiac Disease among Children in Finland
Markku Mäki, K. Mustalahti, Jorma Kokkonen et al. · New England Journal of Medicine · 2003 · 970 citations · Full text
Life Sciences, Genetics, Immunology +17
The impact of irritable bowel syndrome on health-related quality of life
Ian M. Gralnek, Ron D. Hays, Amy M. Kilbourne et al. · Gastroenterology · 2000 · 772 citations · Full text
Increased Prevalence and Mortality in Undiagnosed Celiac Disease
Alberto Rubio‐Tapia, Robert A. Kyle, Edward L. Kaplan et al. · Gastroenterology · 2009 · 769 citations · Full text